On Thursday, Shares of American Capital, Ltd. (NASDAQ:ACAS), lost -2.79% to $14.49.
American Capital, declared that an associate, ACAS CLO 2015-1, Ltd., has closed on the sale of $552 million of collateralized loan obligation bonds. The transaction was arranged by Deutsche Bank Securities, Inc. ACAS CLO 2015-1 is externally managed by American Capital CLO Administration, LLC, which is a partner of American Capital Asset Administration, LLC, a wholly owned portfolio company of American Capital, for an annual administration fee of 50 basis points on total assets.
ACAS CLO 2015-1 has invested the proceeds of the bonds primarily in broadly syndicated senior secured floating rate loans purchased in the primary and secondary markets. American Capital Asset Administration, LLC manages about $3.3 billion of loan and loan-related assets in seven American Capital CLOs, in the equity of about 55 third-party CLOs and American Capital Senior Floating, Ltd. (ACSF) as of March 31, 2015.
American Capital, Ltd. is a private equity and venture capital firm specializing in administration and employee buyouts, subordinated debt, leveraged finance, mezzanine, acquisition, recapitalization, middle market, early venture, mature, industry consolidation, and growth capital investments.
Shares of Johnson & Johnson (NYSE:JNJ), gained 0.49% to $99.66, during its last trading session.
Johnson & Johnson, declared a first-of-its-kind partnership that enlists a third party to review requests made to the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) for compassionate use of its investigational medicines. This new approach will start as a pilot program focused on a single Janssen investigational medicine and, if successful, will become a model that will be applicable more broadly across Johnson & Johnson.
In keeping with the company’s long-standing commitment to the highest standards of ethical decision-making that serves the needs of patients, Janssen Research & Development, LLC, has forged this new partnership with the Division of Medical Ethics at the NYU School of Medicine to obtain independent advice, further ensuring that the evaluation of requests for investigational medicines preceding to their approval by the U.S. Food and Drug Administration (FDA) or other global health authorities are treated in the most fair and ethical manner.
As part of this collaboration, the NYU School of Medicine will establish the Compassionate-Use Advisory Committee (CompAC), an external group of 10 internationally recognized medical experts, bioethicists and patient representatives to pilot the new approach. Commencing with one of Janssen’s investigational medicines, the CompAC will make recommendations regarding individual patient requests from anywhere in the world. Investigational medicines are still in development and usually limited in supply, and the committee’s careful consideration and recommendations based on its independent review will inform Janssen clinicians, who will make the final decision.
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
At the end of Thursday’s trade, Shares of ArcelorMittal (NYSE:MT), lost -3.30% to $10.26.
ArcelorMittal, declared results for the three month period ended March 31, 2015.
Highlights:
- Health and safety: LTIF rate of 0.88x in 1Q 2015 as contrast to 0.89x in 4Q 2014
- EBITDA of $1.4 billion in 1Q 2015 (counting $0.1 billion onerous contract provision)[2], as compared to $1.8 billion in 1Q 2014
- Despite noteworthy forex headwinds, 1Q 2015 underlying steel-only EBITDA stable as compared to 1Q 2014,
- Net loss of $0.7 billion in 1Q 2015 (primarily forex driven) as contrast to a net loss of $0.2 billion in 1Q 2014
- Steel shipments of 21.6Mt, an enhance of 3% as contrast to 21Mt in 1Q 2014
- 6 Mt own iron ore production, an enhance of 5% as contrast to 14.8 Mt in 1Q 2014; 9.4 Mt shipped and stated at market prices as contrast to 9.3 Mt in 1Q 2014
- Iron ore unit cash costs down 13% YoY; FY 2015 cost reduction target raised to 15% (from 10% formerly)
- Net debt of $16.6 billion as of March 31, 2015 as contrast to $18.5 billion at March 31, 2014.
ArcelorMittal, together with its auxiliaries, operates as an integrated steel and mining company worldwide. The company operates through five segments: NAFTA; Europe; Brazil and Neighboring Countries (Brazil); Africa & Commonwealth of Independent States (ACIS); and Mining.
Finally, Exelon Corporation (NYSE:EXC), ended its last trade with 1.17% gain, and closed at $33.83.
To support residents of Baltimore as the city continues to recover from recent events and assist set the stage for long-term solutions, Exelon Corporation, and its Baltimore-based companies BGE and Constellation have declared a joint donation of $200,000 to nonprofits that are leading response efforts.
In order to address immediate needs and support sustainable long-term programs, the companies will donate $100,000 to the Maryland Unites Fund, established by the United Way of Central Maryland in partnership with the State of Maryland, to provide humanitarian aid and emergency supplies to affected neighborhoods. The companies also will contribute $100,000 to the Baltimore Community Foundation for the recently established Fund for Rebuilding Baltimore to assist rebuild damaged businesses and support a sustained effort to address longer-term community needs. One hundred percent of the funds will be used in direct support of these initiatives.
In addition to the immediate financial donation, the companies are also collaborating with city and community leaders and organizations on longer-term initiatives focused on job training and employment opportunities, youth development and strengthening neighborhood resources.
Exelon Corporation, a utility services holding company, engages in the energy generation and delivery businesses in the United States. It owns electric generating facilities, such as nuclear, fossil, and hydroelectric generation facilities, in addition to wind and solar photovoltaic facilities.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
